<abstract xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">The aim of the present study was to investigate the potential of nanoemulsion formulations for transdermal delivery of celecoxib (CXB). The <italic>in vitro</italic> skin permeation profile of optimized formulations was compared with CXB gel and nanoemulsion gel. Significant increase in the steady state flux (<italic>J</italic>ss), permeability coefficient (<italic>K</italic>p) and enhancement ratio (<italic>E</italic>r) was observed in nanoemulsion formulations T1 and T2 (<italic>p</italic> &lt; 0.05). The highest value of these permeability parameters was obtained in formulation T2, which consisted of 2% (<italic>m/m</italic>) of CXB, 10% (<italic>m/m</italic>) of oil phase (Sefsol 218 and Triacetin), 50% (<italic>m/m</italic>) of surfactant mixture (Tween-80 and Transcutol-P) and 40% (<italic>m/m</italic>) water. The anti-inflammatory effects of formulation T2 showed a significant increase (<italic>p</italic> &lt; 0.05) in inhibition after 24 h compared to CXB gel and nanoemulsion gel on carrageenan-induced paw edema in rats. These results suggested that nanoemulsions are potential vehicles for improved transdermal delivery of CXB.</abstract>

The aim of the present study was to investigate the potential of nanoemulsion formulations for transdermal delivery of celecoxib (CXB). The in vitro skin permeation profile of optimized formulations was compared with CXB gel and nanoemulsion gel. Significant increase in the steady state flux (Jss), permeability coefficient (Kp) and enhancement ratio (Er) was observed in nanoemulsion formulations T1 and T2 (p < 0.05). The highest value of these permeability parameters was obtained in formulation T2, which consisted of 2% (m/m) of CXB, 10% (m/m) of oil phase (Sefsol 218 and Triacetin), 50% (m/m) of surfactant mixture (Tween-80 and Transcutol-P) and 40% (m/m) water. The anti-inflammatory effects of formulation T2 showed a significant increase (p < 0.05) in inhibition after 24 h compared to CXB gel and nanoemulsion gel on carrageenan-induced paw edema in rats. These results suggested that nanoemulsions are potential vehicles for improved transdermal delivery of CXB.

Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib

Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard (Hamdard University), New Delhi-110062, India

Acta Pharmaceutica

The aim of the present study was to investigate the potential of nanoemulsion formulations for transdermal delivery of celecoxib (CXB). The in vitro skin...

Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib

Pubblicato online: 18 set 2007

Pagine: 315 - 332

DOI: https://doi.org/10.2478/v10007-007-0025-5

Parole chiave
celekoksib, nanoemulzije, mikroemulzije, nanoemulzijksi gel, transdermalna primjena, protuupalno djelovanje

This content is open access.

Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib

Pubblicato online: 18 set 2007

Pagine: 315 - 332

DOI: https://doi.org/10.2478/v10007-007-0025-5

Parole chiavecelekoksib, nanoemulzije, mikroemulzije, nanoemulzijksi gel, transdermalna primjena, protuupalno djelovanje

This content is open access.

Parole chiave
celekoksib, nanoemulzije, mikroemulzije, nanoemulzijksi gel, transdermalna primjena, protuupalno djelovanje